ARCHIVES

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

This article is from The Cancer Letter archive.

Vol. 02 No. 22 | May 28, 1976

Download PDF Visit The Full Archive

Related Articles

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

ASTRO Announces Election Results, Staff Restructuring

September 17, 2010

In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction

August 21, 1981

NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol

July 25, 1997

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

October 6, 2000